23 June 2025
To: Regulatory Affairs Division
National Medicines Agency
Subject: Submission of Clinical Trial Application â€“ Protocol CTL-2025-001
Dear Sir/Madam,
On behalf of PharmaNova Inc., we are pleased to submit the application package for the
Phase IIb clinical trial enrolling 150 patients to evaluate Drug X.
Documents included in this submission:
1. Protocol CTL-2025-001 Version 1.0
2. Investigator's Brochure Version 2.0
3. Informed Consent Form Version 1.0
4. Statistical Analysis Plan Version 1.0
We confirm that the package is complete and complies with current regulations.
Sincerely,
Jane Doe
Director, Regulatory Affairs
PharmaNova Inc.